Evaluation of Reflex Tear Production
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Alcon Call Center
- Phone Number: 1-888-451-3937
- Email: alcon.medinfo@alcon.com
Study Locations
-
-
California
-
Newport Beach, California, United States, 92663
- Eye Research Foundation
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Key Inclusion Criteria:
- Within the last 12 months, have a previous history of dry eye disease, either clinician diagnosed or patient reported.
- Within the last 6 months, have used, or desired to use artificial tears for dry eye symptoms.
- Corrected Visual Acuity (Snellen) 20/200 or better in both eyes.
- Good general and ocular health, as determined by the investigator using medical history, ophthalmic examination and history.
- Able, as assessed by the investigator, and willing to follow study instructions.
- Other protocol-specified inclusion criteria may apply.
Key Exclusion Criteria:
- Current evidence of any clinically significant ophthalmic disease other than dry eye (for example, glaucoma or macular degeneration).
- Use of artificial tears within 2 hours of the Study Visit.
- History of ocular surgery within 1 year of the Study Visit.
- Use of contact lenses in either eye within 7 days of the Study Visit.
- Use of lid hygiene (all forms of lid care) or heat masks within 7 days of the Study Visit.
- Use of any topical ocular anti-inflammatory medications, any topical ocular corticosteroid, or any non-steroidal-anti-inflammatory agents within 30 days of the Study Visit.
- Other protocol-specified exclusion criteria may apply.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Nasal Stimulation
The Investigator will insert cotton swabs into both nostrils of the subject and gently probe the nasal middle cavities.
Stimulation will stop once visible and obvious reflex tearing has begun.
|
Nostril probing for the purpose of producing reflex tearing
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in TMH immediately following stimulation
Time Frame: Day 1 pre-stimulation (Baseline); Day 1 immediately post-stimulation
|
TMH (the distance between the line of reflection along the top of the tear prism to the edges of the eyelids) will be measured in millimeters using OCT, a non-invasive imaging test that uses light waves to take cross-section pictures of the eye.
TMH will be assessed prior to nasal stimulation and upon completion of nasal stimulation.
Only one eye will be assessed by OCT.
|
Day 1 pre-stimulation (Baseline); Day 1 immediately post-stimulation
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Clinical Trial Lead, Pharma, Alcon Research, LLC
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DEF512-E004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.